Education
About Us
Working with TipRanks
Follow Us
Alphatec Holdings (ATEC)
NASDAQ:ATEC
Earnings Data
Report Date
Apr 30, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.11Same Quarter Last Year
Strong Buy
Based on 11 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call portrayed a company with strong top‑line momentum, expanding profitability, improving gross margins, meaningful surgeon adoption, and a rich product and pipeline roadmap. Key positives include double‑digit revenue growth (20% Q4, 25% FY), substantial adjusted EBITDA expansion (61% Q4, +$63M FY), a solid cash position, and upgraded 2026 EBITDA guidance. Near‑term headwinds are limited and mostly operational or structural: modest full‑year free cash flow in 2025, international mix lowering per‑case revenue, a shift in seasonality that may complicate quarter‑to‑quarter cadence, and some investor pushback reflected in after‑hours trading. Overall, the highlights materially outweigh the lowlights.Company Guidance
Strong Top-Line Growth (Q4 and Full Year)
Q4 2025 revenue of $213,000,000, up 20% year‑over‑year and up $16,000,000 sequentially; full‑year 2025 revenue of $764,000,000, up 25% year‑over‑year (a $153,000,000 increase).
Surgical Revenue Momentum
Q4 surgical revenue of $190,000,000, up 21% year‑over‑year; full‑year surgical revenue of $687,000,000, up 26% year‑over‑year. Procedural volume growth of 21% in Q4 and 22% for the full year; net new surgeon users increased 23% in Q4 and surgeon user base grew ~20% in 2025.
Profitability and Margin Expansion
Q4 adjusted EBITDA of $33,000,000, up 61% year‑over‑year and representing a 16% exit adjusted EBITDA margin; full‑year adjusted EBITDA of $93,000,000 (12% of sales), an increase of $63,000,000 year‑over‑year and +720 basis points versus 2024.
Improving Gross Margin and Operating Leverage
Non‑GAAP gross margin ~70.5% in Q4 (up 80 basis points YoY) and 70.2% for the full year; non‑GAAP SG&A improved as a percent of sales to ~55% in Q4 and ~59% for the year, reflecting operating leverage from revenue growth.
Cash Position and Quarter Cash Generation
Ended Q4 with $161,000,000 cash on hand and $60,000,000 undrawn revolver (total available cash $221,000,000). Generated $8,000,000 free cash flow in Q4 and $21,000,000 of cash from operations in the quarter. Full‑year operating cash flow was $45,000,000.
Product and Procedural Advancements
Multiple new product and capability releases in 2025: EOS Insight and bone mineral density test, EOS pediatric tools, cervical retractor and SPS plating system, full line of 3D‑printed implants, corpectomy device, biologics, and a strengthened neuromonitoring platform (SafeOp).
Strategic Technology Roadmap (Valence & EOS)
Valence (navigation + robotically controlled precision) slated for controlled release in 2026; EOS Edge installed base growth driving access and implant usage increases, with EOS Insight still underpenetrated (growth opportunity).
Partnership and Pipeline Opportunities
Signed exclusive distribution partnership with Theradaptive for a next‑generation BMP with faster bone formation and projected higher safety margin—represents a meaningful long‑term pipeline opportunity in a large BMP market.
Upgraded 2026 Profitability Guidance
2026 revenue guidance of approximately $890,000,000 (17% growth) and raised adjusted EBITDA guidance to $134,000,000 (15% margin). Company expects at least $20,000,000 of free cash flow in 2026 and continued margin expansion toward ~71% gross margin exit.
ATEC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ATEC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 24, 2026 | $13.93 | ― | ― |
Oct 30, 2025 | $16.33 | $18.99 | +16.29% |
Jul 31, 2025 | $10.58 | $13.77 | +30.15% |
May 01, 2025 | $11.06 | $12.00 | +8.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Alphatec Holdings (ATEC) report earnings?
Alphatec Holdings (ATEC) is schdueled to report earning on Apr 30, 2026, After Close (Confirmed).
What is Alphatec Holdings (ATEC) earnings time?
Alphatec Holdings (ATEC) earnings time is at Apr 30, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ATEC EPS forecast?
ATEC EPS forecast for the fiscal quarter 2026 (Q1) is -0.01.